Cargando…

Interplay between Partial EMT and Cisplatin Resistance as the Drivers for Recurrence in HNSCC

This study aims to investigate the role of partial epithelial to mesenchymal transition (pEMT)-related proteins in modulating Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC). SCC-25 cells were pre-treated with TGF-beta1 followed by transient Krüppel-like Factor 4 (KLF4)-overexp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingruber, Julia, Dudas, Jozsef, Sprung, Susanne, Lungu, Bianca, Mungenast, Felicitas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598677/ https://www.ncbi.nlm.nih.gov/pubmed/36289744 http://dx.doi.org/10.3390/biomedicines10102482

Ejemplares similares

KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
por: Ingruber, Julia, et al.
Publicado: (2021)

Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
por: Savic, Dragana, et al.
Publicado: (2023)

Interplay between tumor microenvironment and partial EMT as the driver of tumor progression
por: Aggarwal, Vaishali, et al.
Publicado: (2021)

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer
por: Steinbichler, T. B., et al.
Publicado: (2020)

EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma
por: Ingruber, Julia, et al.
Publicado: (2022)

Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2015)

Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
por: Dudás, József, et al.
Publicado: (2020)

Hepatitis B Virus Reactivation Following Treatment of HNSCC With Cisplatin
por: Crosby, James, et al.
Publicado: (2022)

Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
por: Huang, Jingwen, et al.
Publicado: (2016)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

Next-Generation Digital Histopathology of the Tumor Microenvironment
por: Mungenast, Felicitas, et al.
Publicado: (2021)

Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal
por: Yin, Xiteng, et al.
Publicado: (2018)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC
por: Wu, Lei, et al.
Publicado: (2023)

Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016)

EMT and Tumor Turning Point Analysis in 3D Spheroid Culture of HNSCC and Mesenchymal Stem Cells
por: Brylka, Sabine, et al.
Publicado: (2022)

Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2019)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
por: Liu, Shutong, et al.
Publicado: (2017)

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
por: Tanabe, Shihori, et al.
Publicado: (2020)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)()
por: Almeida, Luciana O., et al.
Publicado: (2013)

Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
por: Ray, Tania, et al.
Publicado: (2021)

Estrogen Biosynthesis and Action in Ovarian Cancer
por: Mungenast, Felicitas, et al.
Publicado: (2014)

The effect of sodium butyrate and cisplatin on expression of EMT markers
por: Mrkvicova, Alena, et al.
Publicado: (2019)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
por: Panchal, Omkar, et al.
Publicado: (2020)

A landscape view on the interplay between EMT and cancer metastasis
por: Li, Chunhe, et al.
Publicado: (2018)

HPV-Induced Oropharyngeal Cancer and the Role of the E7 Oncoprotein Detection via Brush Test
por: Borena, Wegene, et al.
Publicado: (2020)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
por: Tang, Yaqi, et al.
Publicado: (2020)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study
por: Brunner, Teresa F., et al.
Publicado: (2022)

STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma
por: Morelli, Ana Paula, et al.
Publicado: (2021)

An increase of CD8(+) T cell infiltration following recurrence is a good prognosticator in HNSCC
por: So, Yoon Kyoung, et al.
Publicado: (2020)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
por: Haslehurst, Alexandria M, et al.
Publicado: (2012)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer
por: Riechelmann, Herbert, et al.
Publicado: (2021)

Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study
por: Brunner, Teresa F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r70atj3q5j1jeasjcnqn53pgl2